Benchlight The federal appellate judiciary

This writing

Type
Opinion
Filed
Sept. 9, 2024
Case
Kemp v. Regeneron Pharm., Inc.
Case status
Decided

Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.

Opening text

The first passage of the document, as extracted by the source provider.

23-174-cv Kemp v. Regeneron Pharm., Inc. United States Court of Appeals for the Second Circuit August Term, 2023 (Argued: January 25, 2024 Decided: September 9, 2024) Docket No. 23-174-cv _____________________________________ DENISE KEMP, Plaintiff-Appellant,…

Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.

Read the full document (court PDF)